CINECA IRIS Institutional Research Information System

OLIVERO, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.921
EU - Europa 2.159
AS - Asia 1.242
AF - Africa 41
OC - Oceania 19
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.855
CN - Cina 622
IT - Italia 445
SE - Svezia 307
IE - Irlanda 296
SG - Singapore 289
DE - Germania 177
FR - Francia 169
UA - Ucraina 167
FI - Finlandia 159
GB - Regno Unito 125
KR - Corea 122
DK - Danimarca 98
AT - Austria 83
PL - Polonia 66
CA - Canada 64
VN - Vietnam 57
IN - India 48
SN - Senegal 29
ID - Indonesia 28
JP - Giappone 25
BE - Belgio 21
AU - Australia 19
TW - Taiwan 15
NL - Olanda 13
ES - Italia 10
RU - Federazione Russa 10
NG - Nigeria 9
HK - Hong Kong 8
TR - Turchia 7
CH - Svizzera 5
UZ - Uzbekistan 5
IR - Iran 4
BR - Brasile 3
CL - Cile 3
EG - Egitto 3
PK - Pakistan 3
RO - Romania 3
CZ - Repubblica Ceca 2
MX - Messico 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
PE - Perù 1
Totale 7.390
Salva come PNG Salva come JPEG
Città #
Chandler 642
Beijing 376
Dublin 295
Ann Arbor 271
Houston 227
Singapore 204
Fairfield 200
Ashburn 185
Dearborn 136
Wilmington 128
Woodbridge 122
Jacksonville 121
Nyköping 112
Villeurbanne 108
Medford 106
Torino 102
Princeton 98
Seattle 82
Vienna 81
Columbus 80
Cambridge 66
Warsaw 62
Turin 61
Pisa 44
Dong Ket 43
Milan 42
Boston 40
Fremont 35
Guangzhou 33
Jakarta 28
Boardman 26
Santa Clara 26
Norwalk 25
Munich 24
Toronto 22
New York 21
Brussels 20
Hefei 20
Washington 20
Nanjing 19
Verona 19
Kunming 18
Redwood City 18
Ottawa 17
Shanghai 17
Los Angeles 15
Lachine 14
Taipei 14
Mangalore 13
San Diego 13
Nanchang 11
Jinan 10
Wuhan 10
Silver Spring 9
Turku 9
Abuja 8
Wayne 8
Buffalo 7
Chengdu 7
Dallas 7
Paris 7
Tsukishima 7
Chennai 6
Düsseldorf 6
Nuremberg 6
Tokyo 6
Upper Marlboro 6
Utrecht 6
Xian 6
Zhengzhou 6
Harbin 5
Hebei 5
Helsinki 5
London 5
Montréal 5
Naples 5
Phoenix 5
Pune 5
Bologna 4
Carrara 4
Changsha 4
Edinburgh 4
Falls Church 4
Florence 4
Hangzhou 4
Manchester 4
Parma 4
Savigliano 4
Shenyang 4
Amsterdam 3
Bengaluru 3
Berlin 3
Fuzhou 3
Hillsborough 3
Hong Kong 3
Lodi 3
Mountain View 3
Rome 3
Santiago 3
Acton 2
Totale 4.775
Salva come PNG Salva come JPEG
Nome #
Reproducible bioinformatics project: A community for reproducible bioinformatics analysis pipelines 370
PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy 323
rCASC: reproducible classification analysis of single-cell sequencing data 313
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging 194
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 153
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer. 149
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. 145
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. 145
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. 132
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 132
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 120
17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters 117
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. 115
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells 113
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 111
Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients 107
Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell PI3K-Akt signaling pathway and actin cytoskeleton 105
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein 104
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 104
Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin 100
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining 99
RNA-seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls 97
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. 95
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma 95
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1. 94
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. 93
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism 91
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo 90
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C 88
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. 88
Identification of Actionable Cancer Genes and Treatment Options for Metastatic Ovarian Carcinomas using Patient Derived Xenografts (PDXs) and PDX Derived Tumor Cells (PDTCs) 86
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression 83
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C 82
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS 79
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. 78
Control of invasive growth by the HGF receptor family. 77
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. 77
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. 75
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway 75
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer 75
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. 74
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 74
The c-met/HGF receptor in human tumours. 73
Overexpression of the met/HGF receptor in renal cell carcinomas. 70
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 70
Molecular characterization and activation of AKT oncogene in feline mammary tumors 67
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling 67
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer 66
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin 66
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis 65
Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid. 64
The MET-oncogene transforms human primary cultures of bone-derived cells by targeting osteo-progenitors. 63
Selective expression of the Met/HGF receptor in human central nervous system microglia 62
Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice 62
Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. 61
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion 59
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 59
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs 59
MET overexpression turns human primary osteoblasts into osteosarcomas 59
MET receptor is overexpressed but not mutated in oral squamous cell carcinomas 58
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. 58
Shortening of the bones of the hand in genetically characterized PHP-la patients. 57
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 56
Genetics in renal cancer 56
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel 56
Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer 53
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas 51
Expression of the MET/HGF receptor in human pancreatic cancer 50
Expression of the Met/HGF receptor in normal and neoplastic human tissues 50
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells 50
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition 50
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. 49
Overexpression of the Met/HGF receptor in ovarian cancer. 47
Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. 47
Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. 46
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer 46
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas 44
Different mirna profiles in plasma derived small and large extracellular vesicles from patients with neurodegenerative diseases 44
CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system 43
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma 42
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases 41
Quantitative HER2/neu gene expression in feline mammary tumors 40
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 40
Retrogenic expression of the Met/HGF receptor gene induces an invasive phenotype in human rhabdomyosarcomas. 39
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas 39
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. 38
null 33
null 31
MET-oncogene transforms human bone-derived cells by targeting committed progenitors. 30
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 29
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. 28
The MET oncogene transformed human primary cultures of bone-derived cells by targeting osteo-progenitors 21
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 20
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells 18
Results of 149 mobile bearing postero-stabilized TKA at average of 7 years follow-up: analysis of prognostic factors influencing outcomes. 18
Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma 12
Single-Cell RNAseq Data QC and Preprocessing 8
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model 4
Totale 7.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.205
article - articoli 0
book - libri 0
conference - conferenze 5.421
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020953 0 0 0 0 87 228 157 70 129 112 105 65
2020/2021932 97 62 70 57 88 54 81 54 108 99 59 103
2021/2022914 26 37 41 56 22 30 57 45 30 62 242 266
2022/20231.655 174 146 64 172 155 376 103 103 190 20 87 65
2023/2024689 86 123 39 34 30 126 28 38 5 44 48 88
2024/2025453 23 174 73 171 12 0 0 0 0 0 0 0
Totale 7.651